Utama › Kanser Endometrium › Oregon › Eugene
Kajian klinikal Kanser Endometrium di Eugene, OR
8 kajian untuk Kanser Endometrium sedang mencari peserta di lokasi dalam dan sekitar Eugene (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Mengambil pesertaFasa 3
- Oncology Associates of Oregon, P.C. ( Site 8005), Eugene
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Mengambil pesertaFasa 3
- Willamette Valley Cancer Institute and Research Center - Eugene, Eugene
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Mengambil pesertaFasa 3
- Research Site, Eugene
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Mengambil pesertaFasa 1/2
- USOR Oncology Associates of Oregon, P.C., Eugene
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Mengambil pesertaFasa 3
- Research Site, Eugene
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Mengambil pesertaFasa 2
- 517, Eugene
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Mengambil pesertaFasa 2
- Oncology Associates of Oregon, P.C., Eugene
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Mengambil pesertaFasa 2/3
- Oncology Associates of Oregon, Eugene
Kajian Kanser Endometrium di bandar lain
- Houston, TX68 kajian
- New York City, NY52 kajian
- Boston, MA50 kajian
- Arlington, VA39 kajian
- Nashville, TN38 kajian
- Los Angeles, CA34 kajian
- St. Louis, MO29 kajian
- Philadelphia, PA28 kajian
- San Antonio, TX27 kajian
- Queens, NY25 kajian
- Columbus, OH25 kajian
- Chicago, IL25 kajian
Kajian lain di Eugene
- Kanser Paru-paru Bukan Sel Kecil13 kajian
- Kanser Ovari9 kajian
- Kanser Payudara7 kajian
- Leukemia Limfositik Kronik6 kajian
- Mieloma Pelbagai6 kajian
- Kanser Metastatik6 kajian
- Kanser (semua jenis)6 kajian
- Penggunaan dan Ketagihan Ubat5 kajian
- Kanser Paru-paru5 kajian
- Degenerasi Makula5 kajian
- Obesiti4 kajian
- Kanser Prostat3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.